Altheos, Inc.

In Vitro Diagnostics Crescent Diagnostics Ltd. Crescent Diagnostics brings in €1.5mm through its Series A round Crescent Diagnostics Ltd. (test for risk of hip fractures) has raised €1.5mm ($2.2mm

A competitive market and the impending patent expiry of blockbuster Xalatan mean biotech companies and their venture backers must place their bets carefully. For developers of new glaucoma medicines a

ROCK-ing glaucoma prevention 601 Gateway Boulevard Suite 250 South San Francisco, CA 94080 Phone: (650) 989-8570 Web Site: www.altheos.com Contact: Henry Hsu, MD, CEO Industry Segment: Biotechnology B

New Drugs For Glaucoma At its inception, Altheos Inc. licensed a series of selective Rho-kinase inhibitors for glaucoma from Asahi Kasei Pharma, and it plans to move the lead candidate into clinic